Fresenius Medical Care AG
FMS23.060USD
+0.315+1.38%
收盤 01/09, 16:00（美東）報價延遲15分鐘
6.68B總市值
16.96本益比TTM
關於 Fresenius Medical Care AG 公司
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Fresenius Medical Care AG簡介
公司代碼FMS
公司名稱Fresenius Medical Care AG
上市日期Oct 02, 1996
CEOCordola (Craig)
員工數量111513
證券類型Depository Receipt
年結日Oct 02
公司地址Else-Kroener-Strasse 1
城市BAD HOMBURG VOR DER HOHE
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Germany
郵編61352
電話4961726090
網址https://www.freseniusmedicalcare.com/
公司代碼FMS
上市日期Oct 02, 1996
CEOCordola (Craig)
Fresenius Medical Care AG公司高管
名稱
名稱/職務
職務
持股
持股變動
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Martin Fischer
Mr. Martin Fischer
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Mr. Michael Sen
Mr. Michael Sen
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
收入明細
單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
由於公司未披露，未能獲取相關數據
地區USD
名稱
營收
佔比
North America
14.78B
70.68%
Rest of the world
5.61B
26.84%
Germany
518.03M
2.48%
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
其他
94.20%
持股股東
持股股東
佔比
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
其他
94.20%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
5.15%
Investment Advisor
2.13%
Hedge Fund
0.35%
Research Firm
0.25%
Pension Fund
0.14%
Family Office
0.02%
Bank and Trust
0.01%
其他
91.95%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
346
46.58M
8.04%
-2.99M
2025Q3
337
47.00M
8.12%
-7.47K
2025Q2
350
47.02M
8.22%
+2.00M
2025Q1
348
45.04M
8.08%
-2.40M
2024Q4
337
43.94M
8.01%
+456.34K
2024Q3
325
43.49M
7.70%
+2.26M
2024Q2
343
41.23M
8.48%
-1.66M
2024Q1
362
42.90M
8.31%
-5.86M
2023Q4
362
42.80M
8.39%
+76.36K
2023Q3
367
42.72M
8.58%
-1.02M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Pzena Investment Management, LLC
14.82M
2.56%
+153.87K
+1.05%
Sep 30, 2025
Wellington Management Company, LLP
8.20M
1.42%
--
--
Sep 30, 2025
Fiduciary Management, Inc.
5.46M
0.94%
-198.98K
-3.52%
Sep 30, 2025
Dodge & Cox
3.83M
0.66%
--
--
Sep 30, 2025
Todd Asset Management LLC
1.30M
0.22%
+64.31K
+5.19%
Sep 30, 2025
Aristotle Capital Management, LLC
1.13M
0.2%
-7.00K
-0.61%
Sep 30, 2025
Parametric Portfolio Associates LLC
985.01K
0.17%
+12.65K
+1.30%
Sep 30, 2025
Morgan Stanley & Co. International Plc
908.00K
0.16%
-350.00K
-27.82%
Sep 30, 2025
Janus Henderson Investors
829.14K
0.14%
+300.92K
+56.97%
Jun 30, 2025
Kentucky Teachers' Retirement System
816.20K
0.14%
+62.70K
+8.32%
Sep 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Cultivar ETF
1.01%
ActivePassive International Equity ETF
0.08%
Avantis Responsible International Equity ETF
0.06%
Avantis International Equity ETF
0.01%
Pacer Developed Markets International Cash Cws 100
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SGI Enhanced Global Income ETF
0%
Unusual Whales Subversive Republican Trading ETF
0%
The Opal International Dividend Income ETF
0%
查看更多
Cultivar ETF
佔比1.01%
ActivePassive International Equity ETF
佔比0.08%
Avantis Responsible International Equity ETF
佔比0.06%
Avantis International Equity ETF
佔比0.01%
Pacer Developed Markets International Cash Cws 100
佔比0%
Unusual Whales Subversive Democratic Trading ETF
佔比0%
DFA Dimensional International Core Equity 2 ETF
佔比0%
SGI Enhanced Global Income ETF
佔比0%
Unusual Whales Subversive Republican Trading ETF
佔比0%
The Opal International Dividend Income ETF
佔比0%
分紅派息
近5年累計派現
1.59B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
May 07, 2025
FMS.NB Final Cash Dividend of gross USD 0.814968 paid on Jun 06, 2025 going ex on May 23, 2025
May 23, 2025
Jun 06, 2025
May 23, 2025
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Fresenius Medical Care AG的前五大股東是誰？
Fresenius Medical Care AG的前五大股東如下：
Pzena Investment Management, LLC持有股份：14.82M佔總股份比例：2.56%。
Wellington Management Company, LLP持有股份：8.20M佔總股份比例：1.42%。
Fiduciary Management, Inc.持有股份：5.46M佔總股份比例：0.94%。
Dodge & Cox持有股份：3.83M佔總股份比例：0.66%。
Todd Asset Management LLC持有股份：1.30M佔總股份比例：0.22%。
Pzena Investment Management, LLC持有股份：14.82M佔總股份比例：2.56%。
Wellington Management Company, LLP持有股份：8.20M佔總股份比例：1.42%。
Fiduciary Management, Inc.持有股份：5.46M佔總股份比例：0.94%。
Dodge & Cox持有股份：3.83M佔總股份比例：0.66%。
Todd Asset Management LLC持有股份：1.30M佔總股份比例：0.22%。
Fresenius Medical Care AG的前三大股東類型是什麼？
Fresenius Medical Care AG 的前三大股東類型分別是：
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
有多少機構持有Fresenius Medical Care AG(FMS)的股份？
截至2025Q4，共有346家機構持有Fresenius Medical Care AG的股份，合計持有的股份價值約為46.58M，占公司總股份的8.04% 。與2025Q3相比，機構持股有所增加，增幅為-0.08%。
哪個業務部門對Fresenius Medical Care AG的收入貢獻最大？
在FY2024，--業務部門對Fresenius Medical Care AG的收入貢獻最大，創收--，占總收入的--% 。
